GDF2 and epistaxis: Also, we chose to include our patient with a GDF2 VUS and a de novo pathogenic ENG variant because of the interesting possibility of synergy and because both her father and paternal half-brother have clinically significant epistaxis and harbor the same GDF2 VUS.